Acepodia Alternatives & Competitors
12 companies similar to Acepodia — POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
Companies similar to Acepodia
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
Compass Therapeutics Inc.
We are developing next-generation antibodies into transformative cancer therapies that imp...
Boston, United States
ONK Therapeutics
Pioneering optimally engineered NK cell therapies to cure patients with cancer.
Galway, Ireland
Revitope
Powered for Precision: Revolutionizing immunotherapy to safely and effectively treat more...
Cambridge, United States
Track all Acepodia competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Abcuro, Inc
Developing immunotherapies for autoimmune diseases and cancer
ImmunoCellular Therapeutics Ltd
Pioneering immune-based therapies to harness the body's defenses against cancer through ad...
Calabasas, United States
Tessa Therapeutics Ltd
A clinical-stage biotech company developing autologous and allogeneic cell therapies for t...
Singapore, Singapore
Jounce Therapeutics, Inc.
Daring to create a world immune to cancer.
Cambridge, United States
Wugen
Engineering the Next Generation of Off-the-Shelf Cell Therapies
St. Louis, United States
GLIKNIK INC.
Harnessing innovation to empower immune responses and combat cancer with advanced peptide,...
PACT Pharma
PACT Pharma is a privately held biotechnology company developing personalized T cell thera...
South San Francisco, Unit...
About Acepodia
Acepodia is a clinical-stage biotechnology company founded in 2016, with a focus on developing innovative and highly effective cell therapies for cancer patients. The company's slogan, "POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER," encapsulates its mission. Acepodia leverages its Antibody-Cell Conjugat...
Acepodia, Clinical-stage, Cancer Cell Immunotherapy, Off-the-shelf, NK Cells, Antibody-cell Conjugation, Cell Therapy, Oncology, Immune Effector Cells, Solid Tumors, Hematologic Cancers, Immunotherapeutic Strategies, Interdisciplinary Technology
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Acepodia and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Acepodia on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
